Silence Therapeutics (SLN) Non-cash Items (2022 - 2026)

Silence Therapeutics has disclosed Non-cash Items across 5 years of filings, most recently posting $4.5 million for Q1 2026.

• Non-cash Items for Q1 2026 came in at $4.5 million, up 32.06% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.5 million (up 32.06% YoY), and the FY2025 annual result was $4.2 million, down 85.53% from the prior year.
• Non-cash Items came in at $4.5 million for Q1 2026 at Silence Therapeutics, up from $4.2 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $4.5 million in Q1 2026 to a low of $2.2 million in Q4 2022.
• The 5-year median for Non-cash Items is $3.6 million (2025), against an average of $3.5 million.
• Across the five-year window, Non-cash Items dropped 4.47% in 2024 and soared 46.74% in 2025, its largest moves.
• Silence Therapeutics' Non-cash Items stood at $2.2 million in 2022, then jumped by 35.56% to $3.0 million in 2023, then dropped by 4.47% to $2.9 million in 2024, then surged by 46.74% to $4.2 million in 2025, then advanced by 6.92% to $4.5 million in 2026.
• The last three Non-cash Items figures came in at $4.5 million (Q1 2026), $4.2 million (Q4 2025), and $4.0 million (Q3 2025), per Business Quant data.